Axenic Health Solutions
Libertyville, US · Founded 2017 · Delaware corporation
Biotech
Founders & leadership
WS
Warren SkeaExecutive Officer, Director
TE
Todd EvansExecutive Officer, Director
AG
Ahmad GaberExecutive Officer, Director, Promoter
PB
Patrick BeyerDirector
Reported raises · per SEC filings
Form D private placements▶$175KraisedMay 2026 · 3 investors · BiotechnologyRule 506(b)
▶$175KraisedMay 2026 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Warren SkeaExecutive Officer, Director
- Patrick BeyerDirector
- Todd EvansExecutive Officer, Director
- Ahmad GaberDirector
- Offering amount
- $1M
- Amount sold
- $175K
- Minimum investment
- $25K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$180KraisedSep 2025 · 4 investors · BiotechnologyRule 506(b)
▶$180KraisedSep 2025 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Warren SkeaExecutive Officer, Director
- Todd EvansExecutive Officer, Director
- Patrick BeyerDirector
- Offering amount
- $550K
- Amount sold
- $180K
- Minimum investment
- $15K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.2MraisedMay 2020 · 13 investors · BiotechnologyRule 506(b)
▶$3.2MraisedMay 2020 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Warren SkeaExecutive Officer, Director, Promoter
- Todd EvansExecutive Officer, Director, Promoter
- Ahmad GaberExecutive Officer, Director, Promoter
- Offering amount
- $6M
- Amount sold
- $3.2M
- Minimum investment
- $50K
- Proceeds to insiders
- $530K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.